pyrvinium has been researched along with niclosamide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cortinas de Nava, C; Espinosa-Aguirre, JJ; RamÃrez Santos, J | 1 |
| Amoreo, CA; Aria, V; Avvedimento, VE; Bardelli, A; Bosotti, R; Cardone, L; Carrella, D; Ciolli, L; Dattilo, R; di Bernardo, D; Iezzi, M; Isacchi, A; Loreni, F; Manni, I; Mottolese, M; Mutarelli, M; Papaccio, F; Sirci, F; Tumaini, B | 1 |
2 other study(ies) available for pyrvinium and niclosamide
| Article | Year |
|---|---|
Influence of the Uvr repair system on the mutagenicity of antiparasitic drugs.
Topics: Amebicides; Anthelmintics; Chloroquine; DNA Repair; Genes, Bacterial; Mutagens; Niclosamide; Pyrvinium Compounds; Salmonella typhimurium | 1989 |
Computational drugs repositioning identifies inhibitors of oncogenic PI3K/AKT/P70S6K-dependent pathways among FDA-approved compounds.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Carcinogenesis; Cell Line, Tumor; Computational Biology; Drug Approval; Drug Repositioning; Female; Humans; Mammary Glands, Animal; Mice; Niclosamide; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Pyrvinium Compounds; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction | 2016 |